M. R. E. - Madrid - 24/03/2010
VoteResult No interésPoco interesanteDe interésMuy interesanteImprescindible 1 votesPrint Send
Four major research projects on influenza have been selected this year by the European Commission among the 17 that were submitted to the call. Another 49 were added to existing, involving 57 countries (some are international), which means an investment of 100 million euros since 2000.
* A single flu
The news on other sites
* Websites in Spanish
* In other languages
Two of the projects focus on influenza in pigs and the other two in the development of new drugs for influenza in humans. Among the four totaling 18 million euros and involve 52 research institutes and SMEs from 18 European countries and three European countries (China, U.S. and Israel).
"We need the teams working on animal influenza and human influenza do together," explains Draghia-Akli Ruxandra, Director of Health of the European Commission. "This year the new focus of research is on animal surveillance and antiviral drugs."
The project ESNIP 3 is the third phase of the surveillance network for influenza in pigs. It will focus on monitoring the progress of H1N1 in these, to improve diagnosis of influenza virus. It will also strengthen the formal interactions with networks of human and avian surveillance. Spain participates through the Central Veterinary Laboratory Algete (Madrid) and Hipra Laboratories. FLUPIG will focus on adaptive mutations and genetic recombination in pigs and use the ferret as a model of human transmission of the virus.
Flu-Pharm and Flucure, the other two projects are intended, respectively, to study the polymerase enzyme to find new viruses and develop new antiviral drugs that expand the therapeutic arsenal, now poor. In the first involving the CSIC.
Animal
投稿
0 件のコメント:
コメントを投稿